Scilex Holding (SCLX) Preferred Shares (2022 - 2025)
Scilex Holding (SCLX) posted quarterly Preferred Shares of $1000.0 for Q4 2025, little changed on a QoQ basis from $1000.0 in Q3 2025.
Scilex Holding (SCLX) Preferred Shares (2022 - 2025) Analysis & Trends
Scilex Holding (SCLX) has reported Preferred Shares for 3 consecutive years, with $1000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Preferred Shares changed N/A year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $1000.0 (changed N/A YoY), while the FY2025 annual figure was $1000.0, changed N/A from the prior year.
- Preferred Shares came in at $1000.0 for Q4 2025 at Scilex Holding, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Preferred Shares was $3000.0 in Q4 2022, with the low at $1000.0 in Q2 2025.
- Average Preferred Shares over 3 years is $2000.0, with a median of $2000.0 recorded in 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |